S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths

ICU Medical (ICUI) Competitors

$86.25
-1.24 (-1.42%)
(As of 12/8/2023 ET)
Compare
Today's Range
$85.68
$88.89
50-Day Range
$81.08
$119.29
52-Week Range
$78.28
$212.43
Volume
194,568 shs
Average Volume
564,370 shs
Market Capitalization
$2.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$216.00

ICUI vs. NARI, ATRI, MMSI, HAE, ATEC, IRTC, ATRC, AXNX, TNDM, and LMAT

Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Inari Medical (NARI), Atrion (ATRI), Merit Medical Systems (MMSI), Haemonetics (HAE), Alphatec (ATEC), iRhythm Technologies (IRTC), AtriCure (ATRC), Axonics (AXNX), Tandem Diabetes Care (TNDM), and LeMaitre Vascular (LMAT). These companies are all part of the "medical" sector.

ICU Medical vs.

Inari Medical (NASDAQ:NARI) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.

In the previous week, Inari Medical and Inari Medical both had 1 articles in the media. ICU Medical's average media sentiment score of 1.54 beat Inari Medical's score of 0.00 indicating that Inari Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inari Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
ICU Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

87.8% of Inari Medical shares are owned by institutional investors. Comparatively, 91.5% of ICU Medical shares are owned by institutional investors. 11.9% of Inari Medical shares are owned by insiders. Comparatively, 7.5% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Inari Medical has a net margin of -0.59% compared to Inari Medical's net margin of -1.25%. Inari Medical's return on equity of 6.53% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inari Medical-0.59% -0.64% -0.53%
ICU Medical -1.25%6.53%3.08%

Inari Medical currently has a consensus price target of $82.00, suggesting a potential upside of 30.06%. ICU Medical has a consensus price target of $216.00, suggesting a potential upside of 150.43%. Given Inari Medical's higher probable upside, analysts plainly believe ICU Medical is more favorable than Inari Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inari Medical
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
ICU Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Inari Medical has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.

ICU Medical received 330 more outperform votes than Inari Medical when rated by MarketBeat users. However, 69.44% of users gave Inari Medical an outperform vote while only 64.30% of users gave ICU Medical an outperform vote.

CompanyUnderperformOutperform
Inari MedicalOutperform Votes
50
69.44%
Underperform Votes
22
30.56%
ICU MedicalOutperform Votes
380
64.30%
Underperform Votes
211
35.70%

Inari Medical has higher earnings, but lower revenue than ICU Medical. Inari Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inari Medical$469.31M7.74-$29.27M-$0.06-1,050.83
ICU Medical$2.28B0.91-$74.29M-$1.17-73.72

Summary

Inari Medical beats ICU Medical on 9 of the 16 factors compared between the two stocks.


Get ICU Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUI vs. The Competition

MetricICU MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.08B$3.47B$4.51B$6.79B
Dividend YieldN/A3.91%2.94%4.56%
P/E Ratio-73.7223.13106.1614.00
Price / Sales0.9149.342,651.50109.88
Price / Cash5.3249.6883.99124.94
Price / Book0.993.334.054.66
Net Income-$74.29M$58.14M$123.78M$177.35M
7 Day Performance-5.57%0.56%1.14%0.77%
1 Month Performance6.38%24.03%10.52%9.24%
1 Year Performance-43.90%-14.22%9.42%8.19%

ICU Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NARI
Inari Medical
2.1607 of 5 stars
$62.15
-1.0%
$82.00
+31.9%
-9.9%$3.58B$469.31M-1,035.831,100Positive News
ATRI
Atrion
2.7381 of 5 stars
$310.81
-2.4%
N/A-48.4%$547.03M$168.60M25.73722Positive News
MMSI
Merit Medical Systems
2.3904 of 5 stars
$65.53
-11.4%
$85.50
+30.5%
-4.4%$3.78B$1.15B37.886,846News Coverage
High Trading Volume
HAE
Haemonetics
2.2041 of 5 stars
$82.00
-1.5%
$103.40
+26.1%
+1.3%$4.16B$1.17B32.933,034Analyst Downgrade
News Coverage
ATEC
Alphatec
2.1644 of 5 stars
$12.81
+0.5%
$21.86
+70.6%
+31.7%$1.75B$350.87M-8.48705
IRTC
iRhythm Technologies
1.6798 of 5 stars
$85.60
-4.8%
$131.33
+53.4%
-10.0%$2.62B$410.92M-24.741,793
ATRC
AtriCure
1.8056 of 5 stars
$34.80
-4.6%
$60.13
+72.8%
-22.2%$1.65B$330.38M-64.441,050
AXNX
Axonics
2.9793 of 5 stars
$57.21
-1.5%
$71.60
+25.2%
-13.8%$2.90B$273.70M-228.84610News Coverage
Positive News
TNDM
Tandem Diabetes Care
2.5468 of 5 stars
$21.16
-0.3%
$38.50
+81.9%
-45.8%$1.38B$801.22M-6.552,600Positive News
LMAT
LeMaitre Vascular
2.5202 of 5 stars
$54.01
-1.0%
$67.60
+25.2%
+17.5%$1.20B$161.65M44.64591Analyst Downgrade
News Coverage

Related Companies and Tools

This page (NASDAQ:ICUI) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -